| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 05/26/2004 | EP1421082A1 New piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity |
| 05/26/2004 | EP1421075A1 Piperidine derivatives useful as ccr5 antagonists |
| 05/26/2004 | EP1421074A1 Novel compounds |
| 05/26/2004 | EP1421071A2 Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators |
| 05/26/2004 | EP1421070A1 New piperidinyl derivates as modulators of chemokine receptor activity |
| 05/26/2004 | EP1420829A2 Immunomodulatory compositions, formulations, and methods for use thereof |
| 05/26/2004 | EP1420817A1 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments |
| 05/26/2004 | EP1420798A2 Treatment and prevention of heat shock protein-associated diseases and conditions |
| 05/26/2004 | EP1420794A1 Prostaglandin analogs as chloride channel opener |
| 05/26/2004 | EP1420788A1 Novel piperidin-2,6-dione bisulphate salts and their use for the treatment of stress-related affective disorders |
| 05/26/2004 | EP1420785A2 SUBSTITUTED INDENO 1,2-c]ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF |
| 05/26/2004 | EP1420783A1 Stable emulsion composition |
| 05/26/2004 | EP1420760A2 Aerosolized decongestants for the treatment of sinusitis |
| 05/26/2004 | EP1420759A2 Pharmaceutical compositions for the treatment of asthma |
| 05/26/2004 | EP1420745A2 Use of r-nsaid compounds for anti-hiv treatment |
| 05/26/2004 | EP1296996B1 Purine derivatives |
| 05/26/2004 | EP1257553B1 Pyrrolopyrimidinone derivatives, process of preparation and use |
| 05/26/2004 | EP1216245B1 Pharmaceutically active sulfonyl hydrazide derivatives |
| 05/26/2004 | EP1005445B1 N-alkanoylphenylalanine derivatives |
| 05/26/2004 | EP0971741B1 Use of avian antibodies |
| 05/26/2004 | EP0874819B1 Imides as pde iii, pde iv and tnf inhibitors |
| 05/26/2004 | CN1500097A Human monoclonal antibodies to FC Alpha receptor (CD89) |
| 05/26/2004 | CN1500096A Osteoprotegerin in milk |
| 05/26/2004 | CN1500089A Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain |
| 05/26/2004 | CN1500078A Aryl oxime-piperazines useful as CCR5 antagonists |
| 05/26/2004 | CN1499977A Compsns. and method of tissue superoxygenation |
| 05/26/2004 | CN1499969A pharmaceutical formulation contg. pyrazolo[4,3-D] pyrimidine and nitrates or thienopyrimidines and nitrates |
| 05/26/2004 | CN1499960A Chornotherapeutic dosage forms |
| 05/26/2004 | CN1499927A Erythropoietin ameliorates chemotheapy-induced toxicity in vivo |
| 05/26/2004 | CN1498895A Artificial composite deoxygenation oligonucleotide with CpG single chain being contained, and effect of anti SARS virus |
| 05/26/2004 | CN1498651A Medicaton for treating celiaca and its prepn. method |
| 05/26/2004 | CN1498646A Ointment for benefiting lung made from crocodile |
| 05/26/2004 | CN1498640A Powder of Chinese traditional medicine for treating pharyngitis |
| 05/26/2004 | CN1498617A Preparation containing Cetirizine Hydrochloride and hydrochloric pseudoephedrine and its prepn. method |
| 05/26/2004 | CN1151167C Purine derivatives |
| 05/26/2004 | CN1151166C Crystal of diruidine tetraphosphate or salt thereof and method for preparing same, and method for producing said compound |
| 05/26/2004 | CN1151144C Benzopyans and benzothiopyrans as RAR selective retinoid agonists |
| 05/26/2004 | CN1151131C Piperidine derivatives useful as CCR5 antagonists |
| 05/26/2004 | CN1151126C 1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses |
| 05/26/2004 | CN1150927C Stomatopathy and throat disease treating health care medicine and its production process |
| 05/26/2004 | CN1150908C Prodn. method of seahorse powder capsule |
| 05/25/2004 | US6740673 Quarternary ammonium compounds |
| 05/25/2004 | US6740672 Administering alosetron, tropisetron, ondansetron, granisetron and/or bemesetron |
| 05/25/2004 | US6740666 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 05/25/2004 | US6740662 Having 2-oxo-1,2-dihydro- functionality; phosphodiesterase inhibitors |
| 05/25/2004 | US6740655 3',5'-cyclic nucleotide phosphodiesterase 4-specific inhibitors reduce eosinophil influx to the lungs; side effect reduction; antiinflammatory agent; antiallergens; respiratory system disorders, especially asthma |
| 05/25/2004 | US6740647 Amidines and hydroxyamidine derivatives |
| 05/25/2004 | US6740337 Stability |
| 05/25/2004 | CA2048172C Substituted sulfonamids, preparation processes and drugs containing same |
| 05/21/2004 | WO2004042402A2 Diagnostics and therapeutics for diseases associated with human mas-related gene x1 (mrgx1) |
| 05/21/2004 | WO2004042361A2 Transgenic animals expressing light-emitting fusion proteins and diagnostic and therapeutic methods therefor |
| 05/21/2004 | WO2004041867A2 Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders |
| 05/21/2004 | WO2004041865A2 Stabilized single domain antibodies |
| 05/21/2004 | WO2004041863A2 Single domain antibodies directed against interferon- gamma and uses therefor |
| 05/21/2004 | WO2004041862A2 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| 05/21/2004 | WO2004041819A1 Pyrazolonaphthyridine derivative |
| 05/21/2004 | WO2004041309A1 Drugs comprising combination of elastase inhibitor with blood coagulation system and/or fibrinolysis system enzyme inhibitor |
| 05/21/2004 | WO2004041302A1 Pharmaceutical composition comprising a tissue factor antagonist and a blood glucose regulator |
| 05/21/2004 | WO2004041296A2 Pharmaceutical composition comprising a tissue factor antagonist and protein c polypeptides |
| 05/21/2004 | WO2004041282A1 Receptor regulator |
| 05/21/2004 | WO2004041278A1 Use of tacrolimus (fk506) derivatives combined with beta2-agonists for the treatment of asthma |
| 05/21/2004 | WO2004041272A2 Use of serotonin receptor antagonists for the treatment of sleep apnea |
| 05/21/2004 | WO2004041258A2 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
| 05/21/2004 | WO2004005476A3 Nucleic acid compositions for stimulating immune responses |
| 05/21/2004 | WO2004004629A3 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 05/21/2004 | WO2003101455A3 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use |
| 05/21/2004 | WO2003088900A3 Solid forms of salts with tyrosine kinase activity |
| 05/21/2004 | WO2003084935A3 Diaryl pyrimidinone derivatives useful for the treatment of inflammation and immunogolical diseases |
| 05/21/2004 | WO2003055440A8 Compositions and methods for the treatement of immune related diseases |
| 05/21/2004 | CA2505326A1 Camelidae antibodies against immunoglobulin e and use thereof for the treatment of allergic disorders |
| 05/21/2004 | CA2505325A1 Stabilized single domain antibodies |
| 05/21/2004 | CA2505316A1 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| 05/21/2004 | CA2504805A1 Receptor regulator |
| 05/21/2004 | CA2503716A1 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
| 05/21/2004 | CA2499719A1 Use of tacrolimus (fk506) derivatives combined with beta2-agonists for the treatment of asthma |
| 05/20/2004 | US20040097867 Systems and methods for treating patients with processed lipoaspirate cells |
| 05/20/2004 | US20040097730 Amide containing a pyridinone or pyrazinone compound as serine protease enzyme inhibitors |
| 05/20/2004 | US20040097706 Streptococcus pyogenes antigens and corresponding dna fragments |
| 05/20/2004 | US20040097576 Use of tryptophane-derivatives, that are toxicated into specific toxins in body's cell by enzymes tryptophan-hydroxylase and aromatic amino acid decarboxylase of body, for simultaneous reduction and/or disruption of serotonin |
| 05/20/2004 | US20040097563 4-6-Diphenyl pyridine derivatives as antiinflammatory agents |
| 05/20/2004 | US20040097548 For prophylaxis and therapy of from inflammation, allergic disease, pain, migraine headache, neuralgia, itching, cough, central nervous system disease, digestive organs disease, nausea, emesis, urination disorder, circulatory disease |
| 05/20/2004 | US20040097539 Hsp inductor |
| 05/20/2004 | US20040097537 6-phenylbenzonaphthyridines |
| 05/20/2004 | US20040097536 Extended release oral dosage composition |
| 05/20/2004 | US20040097513 Novel non-imidazole compounds |
| 05/20/2004 | US20040097502 For therapy and prophylaxis of disorders characterised by overexpression of transforming growth factor |
| 05/20/2004 | US20040097501 Triazole compounds useful as protein kinase inhibitors |
| 05/20/2004 | US20040097495 Method for treating fibrotic diseases or other indications IIIC |
| 05/20/2004 | US20040097494 For use as nitric oxide synthase inhibitors |
| 05/20/2004 | US20040097493 Diazinopyrimidines |
| 05/20/2004 | US20040097457 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis |
| 05/20/2004 | US20040097455 Cloning of reporter genes and cDNA encoding for therapeutic proteins for the treatment of hepatic, pulmonary, renal, heart, pancreas fibrosis, keloids and hypertrophic scars, in mammals, including human beings |
| 05/20/2004 | US20040097434 For therapy of inflammatory diseases and conditions in humans and animals |
| 05/20/2004 | US20040097425 Peptide compounds |
| 05/20/2004 | US20040096526 Using plant extracts mixtures; extraction, filtration, spray drying; beverages |
| 05/20/2004 | US20040096513 Systemically minimizing the inflammatory effects of TNF- alpha are disclosed. The compositions include particles of bioactive glass with a particle size less than about 20 mu m, alone or in combination with anti-inflammatory agents and |
| 05/20/2004 | US20040096451 Preventing, treating or ameliorating symptoms associated with respiratory syncytial virus (RSV), parainfluenza virus (PIV), and/or human metapneumovirus (hMPV) infection, the methods comprising administering to a subject an effective amount of |
| 05/20/2004 | US20040096435 Methods for screening compounds that modulate lipid metabolism |
| 05/20/2004 | US20040096431 Providing a tissue removal system; removing adipose tissue from a patient using the tissue removal system, the adipose tissue having a concentration of stem cells; processing at least a part of the adipose tissue to obtain a concentration |
| 05/19/2004 | EP1420020A1 4-oxoimidazolidine-2-spiropiperidine derivative |